|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/12 | |
| A61P 31/12 |
| (11) | Patento numeris | 2190535 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08802602.6 |
| Europos patento paraiškos padavimo data | 2008-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-06-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-08-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/008133 |
| Data | 2008-09-09 |
| (87) | Numeris | WO 2009/033805 |
| Data | 2009-03-19 |
| (30) | Numeris | Data | Šalis |
| 07017754 | 2007-09-11 | EP |
| (72) |
BEVEC, Dorian, DE
CAVALLI, Fabio, CH
CAVALLI, Vera, CH
BACHER, Gerald, DE
|
| (73) |
Mondobiotech Laboratories AG,
Herrengasse 21, 9490 Vaduz,
LI
|
| (54) | Somatostatin-14 for use in the prophylaxis and/or treatment of HBV |
| Somatostatin-14 for use in the prophylaxis and/or treatment of HBV |